Premium
Influence of lornoxicam a new non‐steroidal antiinflammatory drug on lithium pharmacokinetics
Author(s) -
Ravic M.,
SalasHerrera I.,
Johnston A.,
Turner P.,
Foley K.,
Rosenow D.
Publication year - 1993
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.470080409
Subject(s) - lornoxicam , pharmacokinetics , lithium carbonate , lithium (medication) , drug , pharmacology , drug interaction , medicine , chemistry , analgesic , organic chemistry , ion , ionic bonding
The pharmacokinetics of lithium carbonate have been studied in 12 normal young volunteers when given alone and in combination with lornoxicam, a novel non‐steroidal anti‐inflammatory drug. Peak and 12‐h lithium concentrations were significantly higher when both drugs were given together than when lithium was given alone. Caution should be exercised if and when the drugs are co‐prescribed.